Endocrine-disrupting pesticides and SARS-CoV-2 infection: Role of ACE2, TMPRSS2 and CD147

Authors

  • Swati Dixit Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India
  • Haseeb Ahsan Department of Biochemistry, Faculty of Dentistry, Jamia Millia Islamia, New Delhi, India
  • Fahim Halim Khan Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India

DOI:

https://doi.org/10.15419/bmrat.v10i9.829

Keywords:

ACE2, cancer, CD147, endocrine disruptors, Pesticides, SARS-CoV-2, TMPRSS2

Abstract

COVID-19 is a global pandemic caused by severe acute respiratory syndrome (SARS) coronavirus- 2 (SARS-CoV-2). The three main receptors used by SARS-CoV-2 to bind and gain entry into human cells are ACE, TMPRSS2, and CD147. These molecular factors have crucial roles in human metabolism and homeostasis, but the upregulation of these factors causes severe diseases such as myocarditis, prostate cancer, and other endocrine-related cancers. Studies have found that once humans come into contact with SARS-CoV-2, the chances of being affected by such disorders increase; indeed, infection with the virus is associated with increased morbidity and mortality from heart attacks and pulmonary inflammation. Notably, exposure to some pesticides, such as chlorpyrifos, cypermethrin, and imidacloprid, which are identified as potential endocrine disruptors, causes such disorders by interfering with hormonal signaling pathways, such as the insulinglucagon pathway and the thyroid pathway. This review focuses on the potential role of pesticides in exacerbating the comorbidities linked with SARS-CoV-2 and their effect on the molecular factors associated with SARS-CoV-2. Understanding the potential therapeutic implications of this link between SARS-CoV-2 severity and pesticides requires further clinical trials and investigations.

Downloads

Published

2023-09-30

Issue

Section

Review

How to Cite

Endocrine-disrupting pesticides and SARS-CoV-2 infection: Role of ACE2, TMPRSS2 and CD147. (2023). Biomedical Research and Therapy, 10(9), 5876-5883. https://doi.org/10.15419/bmrat.v10i9.829

Similar Articles

51-60 of 448

You may also start an advanced similarity search for this article.